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Background: Since hepatocellular carcinoma (HCC) is one of the leading causes of cancer death worldwide, it is
still important to understand hepatocarcinogenesis mechanisms and identify effective markers for tumor
progression to improve prognosis. Amplification and overexpression of Tropomyosin3 (TPM3) are frequently
observed in HCC, but its biological meanings have not been properly defined. In this study, we aimed to elucidate
the roles of TPM3 and related molecular mechanisms.
Methods: TPM3-siRNA was transfected into 2 HCC cell lines, HepG2 and SNU-475, which had shown
overexpression of TPM3. Knockdown of TPM3 was verified by real-time qRT-PCR and western blotting targeting
TPM3. Migration and invasion potentials were examined using transwell membrane assays. Cell growth capacity
was examined by colony formation and soft agar assays.
Results: Silencing TPM3 resulted in significant suppression of migration and invasion capacities in both HCC cell
lines. To elucidate the mechanisms behind suppressed migration and invasiveness, we examined expression levels
of Snail and E-cadherin known to be related to epithelial-mesenchymal transition (EMT) after TPM3 knockdown. In
the TPM3 knockdown cells, E-cadherin expression was significantly upregulated and Snail downregulated
compared with negative control. TPM3 knockdown also inhibited colony formation and anchorage independent
growth of HCC cells.
Conclusions: Based on our findings, we formulate a hypothesis that overexpression of TPM3 activates Snail
mediated EMT, which will repress E-cadherin expression and that it confers migration or invasion potentials to HCC
cells during hepatocarcinogenesis. To our knowledge, this is the first evidence that TPM3 gets involved in
migration and invasion of HCCs by modifying EMT pathway.
Background
Hepatocellular carcinoma (HCC) is one of the most
common human malignancies and the third leading
cause of cancer-related death in the world [1]. A num-
ber of studies have been suggesting the molecular
mechanisms involved in hepatocarcinogenesis such as
MAPK, EGFR, p53, Wnt, TGF-B, Ras and Rb pathways
[2-5]. However, given that prognosis of the disease
remains poor, it is still important to understand hepato-
carcinogenesis mechanisms and to identify effective
markers for early diagnosis and accurate prognostication
which reflect biological phenomena well.
In our recent study which reported the chromosomal
alterations in HCC by genome-wide array-CGH analysis,
we found that a 1q21.3 locus was recurrently amplified
and that a Tropomyosin 3 (TPM3) gene located in this
region was coherently overexpressed in primary HCC
[6]. This evidence suggests that overexpression of TPM3
m a yp l a yar o l ei nH C Ct u m o r i g e n e s i s .T P M 3i sa n
actin-binding protein present in skeletal and smooth
muscle and some non-muscular tissues. In skeletal mus-
cle, TPM3 mediates a myosin-actin response to calcium
ions and takes part in the stabilization of cytoskeletal
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TPM3 in non-muscular tissues is still obscure.
Lines of evidence have suggested that non-muscular
tropomyosins might be involved in tumor development.
TPM3 was reported to be involved in hematopoietic
tumorigenesis by forming a TPM3-ALK fusion through
(1;2) translocation [8,9]. TPM3 is also known as an
inducer of papillary thyroid carcinoma and chronic eosi-
nophilic leukemia through a fusion with NTRK1 and
PDGFRB [10,11]. In addition, tropomyosin family mem-
bers have been reported to be related with tumor cell
movement or invasion [12,13]. In Miyado et al.’so b s e r -
vation, the expression level of a low-molecular weight
tropomyosin isoform, TM5/TM30nm, was higher in a
highly metastatic mouse melanoma cell line than in a
low-metastatic one [14]. This evidence suggests that
overexpression of TPM3 may contribute to invasion or
migration potentials of human malignancies including
HCC, but molecular mechanisms behind this has not
been explored.
In this study, we explored the biological roles of
TPM3 in hepatocarcinogenesis and involved molecular
mechanisms by TPM3 knockdown using small interfer-
ing RNA (siRNA) in human HCC cell lines.
Methods
HCC cell lines
HepG2 was obtained from ATCC (American Type Cul-
ture Collection, Manassas, VA) and maintained in DMEM
(Gibco BLR, Gaithersburg, MD) supplemented with 10%
FBS. SNU-739, 423, 449, 886, 475, 878, 387, 398, and 761
were obtained from the Korean cell-line bank (Seoul,
Korea) and maintained in RPMI 1640 (Hyclone, Logan,
UT) supplemented with 10% FBS at 37°C in humidified air
containing 5% CO2. THLE-3 (a human normal liver cell)
was purchased from ATCC (Manassas, VA) and main-
tained in DMEM supplemented with 10% FBS, 25 mM
HEPES buffer and 100 U/ml of penicillin.
siRNA oligonucleotides
We purchased two synthetic double-stranded oligonu-
cleotides with the following sequences and introduced
them into the pSilencer 3.1-H1 neo siRNA expression
vector (Invitrogen, Carlsbad, CA); TPM3 RNAi-1, AGC
AUU CUC CUU GUC UAA CUU CAG C: GCU GAA
GUU AGA CAA GGA GAA UGC U; TPM3 RNAi-2,
UAA CCU UCA UAC CUC UCU CAC UCU C: GAG
AGU GAG AGA GGU AUG AAG GUU A. To verify
sequence-specific effectiveness of TPM3-RNAi, we used
a negative control siRNA (Invitrogen, Carlsbad, CA)
that has no significant homology with any known
sequences in the human genome.
Transfection of TPM3 siRNAs
We adopted a forward transfection method. In brief,
transfection was performed by adding the mixture of
siRNA and the transfection reagent (lipofectamine RNi-
MAX, Invitrogen, Carlsbad, CA) onto the cells after the
cell seeding. HepG2 and SNU475 cells were seeded at a
density of 200,000 and 100,000 cells/well in six-well
plates, respectively, and incubated for 24 hours at 37°C
with 5% CO2. After 24 hour incubation, HCC cells were
transfected with 100 nM siRNAs (2 TPM3 siRNAs and
an e g a t i v ec o n t r o ls i R N A )u s i n g1 . 2 5μg/ml lipofecta-
mine RNAiMax (Invitrogen, Carlsbad, CA) according to
the manufacturer’s instructions. After 48 hours follow-
ing the transfection, HCC cells were harvested and
silencing of the TPM3 expression was validated by real-
time quantitative RT-PCR (qRT-PCR) and western
blotting.
Quantitative RT-PCR
Total RNA was extracted from the HCC cell lines using
TRIzol (Invitrogen, Carlsbad, CA) according to the man-
ufacturer’s instructions. First-strand complementary
D N A( c D N A )w a ss y n t h e s i z e df r o m5μgo ft o t a lR N A
using oligo-dT primer and superscript II reverse tran-
scriptase (Invitrogen, Carlsbad, CA). To determine the
levels of TPM3 messenger RNA (mRNA) expression,
real-time qRT-PCR was performed using Mx3000P
QPCR System and software MxPro Version 3.00 (Strata-
gene, La Jolla, CA). Reaction mixture was composed of
1×S Y B RG r e e nTbr polymerase Master Mix (FINN-
ZYMES, Finland), 0.5 × ROX and 20 pmol of each
primer, and 10 ng of cDNA. Primers for TPM3 were 5’-
GAGAGGTATGAAGGTTATTCA-3’ for forward and
5’-ATCACCACCTTACGAGCCACC-3’ for reverse.
GAPDH was used as internal control. GAPDH primers
were designed as 5’-GCGGGGCTCCAGAACATCAT-3’
for forward and as 5’- CCAGCCCCAGCGTCAAGGTG-
3’ for reverse. RNA levels of E-Cadherin and Snail
were measured using the following primers according
to previous reports [15,16]; for Snail, 5’ -AAG-
GATCTCCAGGCTCGAAAG-3’ for forward and 5’-
GCTTCGGATGTGCATCTTGA-3’ for reverse; for
E-cadherin, 5’-TCGACACCCGATTCAAAGTGG-3’ for
forward and 5’- TTCCAGAAACGGAGGCCTGAT -3’
for reverse. The PCR program was as follows: denatura-
tion at 95°C for 5 minutes; 40 cycles of 95°C for 30 sec-
onds, 60°C for 30 seconds, and 72°C for 40 seconds
followed by a 72°C elongation step for 6 minutes. Rela-
tive expression quantification was performed by the
ΔΔCT method [17]. All the experiments were repeated
three times and the mean value of intensity ratios with
the SD was plotted for each case.
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Proteins were separated by 10% sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis (PAGE) and
transferred onto polyvinylidene difluoride membranes
(Millipore, Bedford, MA). The membrane was blocked
with 5% non-fat dried milk in TBST(20 mM Tris-HCl,
150 mM NaCl, and 0.1% Tween 20, pH 7.5) for 2 hours
and incubated overnight with antibodies against TPM3
(1:1,000 dilution; Abnova, Taipei, Taiwan), a-tubulin
(1:1,000 dilution; Santa Cruz biotechnology, Santa Cruz,
CA), Snail (1:500 dilution; Abcam, Cambridge, UK), E-
cadherin (1:1000 dilution; Zymed, San Francisco, CA) at
4°C. After the wash with TBST buffer, membranes were
incubated with horseradish peroxidase-conjugated anti
mouse IgG secondary antibodies for 1 hour at room
temperature and detected by enhanced chemilumines-
cence detection system (Amersham-Pharmacia Biotech,
Braunschweig, Germany).
Immunofluorescence staining
The samples of siTPM3 and siNEG transfected cells
(SNU-475 and HepG2) were cytocentrifuged onto the
slides and immediately fixed with ethyl alcohol for 30
minutes. For immunofluorescence staining, slides were
exposed to 0.2% Tween 20 in PBS for 30 minutes and
incubated overnight at 4°C with monoclonal antibo-
dies against vimentin (1:100, clone V9, DakoCytoma-
tion, Glostrup, Denmark) and fibronectin (1:100, clone
5 6 8 ,N o v o c a s t r a ,N e w c a s t l eu p o nT y n e ,U K ) .A f t e r
thorough washing, cells were incubated with a 1:500
dilution of Alexa Fluor 488-conjugated goat anti-
mouse IgG antibody (Invitrogen - Molecular Probes,
Eugene, OR) for 30 minutes at room temperature in
the dark. Staining of nuclei with diaminophenylindole
(Molecular Probes) was also performed. Staining pat-
t e r n sw e r eo b s e r v e db yaf l u orescence microscope
(Carl Zeiss, Axio Imager M1, Oberkochen, Germany)
(400×).
Migration and invasion assays
Migration of HCC cells was assayed using the transwell
with 8-μm pore filters (Costar, Boston, MA). After filling
the lower chamber with complete media, 2 × 10
4 HCC
cells in 0.5 mL serum-free media were loaded onto the
upper chamber. After incubation for 12 hours at 37°C,
cells that migrated to the bottom surface of the mem-
brane were fixed with methanol and stained with 0.5%
crystal violet and then subjected to microscopic inspec-
tion. Cells on the top surface of the membrane were
removed by wiping with a cotton swab. The numbers of
cells were counted in five microscopic fields (×200). For
the Matrigel invasion assay, the procedures were same
as those for the cell migration assay, except that the
transwell membrane was coated with 500 ng/μLo f
Matrigel (BD Biosciences, San Jose, CA) and incubated
for 24 hours at 37°C.
Colony formation and soft agar assays
For the colony formation assay, siRNA-treated and
negative control-treated HCC cells (1 × 10
4)w e r e
seeded in 10 cm dishes. Two weeks later, cells were
washed with PBS buffer and stained with 0.5% crystal
violet in 20% methanol for 20 minutes and the number
of colonies was counted. For the soft agar assay, HCC
cells were suspended in RPMI1640 containing 0.35%
low melting agarose, and plated onto solidified 0.6%
agarose containing RPMI1640 in six-well culture plates
at a density of 1 × 10
5 cells per dish. The number and
size of colonies were observed 3 weeks after seeding
under the microscope (×40).
Statistical Analysis
An independent samples t-test was used to test the sig-
nificance of difference between groups and P values <
0.05 were considered significant. Data were analyzed
using Stata version 10 software (Stata Corporation, Col-
lege Station, TX).
Results
Elevated TPM3 expression in HCC cell lines
We firstly screened baseline TPM3 expression levels in
10 HCC cell lines. In eight out of the 10 HCC cell lines
except for SNU-398 and SNU-886, both the mRNA
(>1.5 fold) and protein expression levels of TPM3 were
found to be increased with respect to the normal liver
cell line (THLE-3) (Figure 1).
Suppression of TPM3 expression by siRNA transfection
For TPM3 knockdown, we transfected two siRNA con-
structs into those 8 cell lines which showed TPM3
overexpression compared with the THLE-3 on both
mRNA and protein levels; siTPM3-1 and siTPM3-2
targeting exons 1 and 3/4, respectively. As a control, a
negative oligonucleotide construct (siNEG) was trans-
fected into the same 8 cell lines. As siTPM3-1 showed
better knockdown effects between the two siRNA con-
structs and the best interfering efficiency was observed
in SNU-475 and HepG2 cell lines (data not shown), all
the downstream functional analyses were performed
using siTPM3-1 (herein after called siTPM3) in these
two cell lines. Figure 2 presents real-time qRT-PCR
and western blotting results showing the repressed
expression of TPM3 induced by transfecting siTPM3.
In HepG2, relative TPM3 mRNA expression ratios
(siTPM or siNEG/no transfection control) were 1.00
(95% CI 0.76-1.24) and 0.04(95% CI 0.03-0.06) in
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Page 3 of 11Figure 1 TPM3 expression levels in various human HCC cell lines. One normal human liver cell line (THLE-3) and 10 types of HCC cell lines
were examined by TPM3-specific real-time qRT-PCR (top plot) and western blot (bottom plot). Human GAPDH gene was used as internal control
for qRT-PCR and alpha-tubulin was used as internal control for western blot analysis. In the top plot, X axis represents cell lines and Y axis
relative TPM3 expression ratios (tumor/normal). Error bars represent mean ± standard error of mean.
Figure 2 Suppressed TPM3 expression after siTPM3 transfection into HepG2 (A) and SNU-475 (B). TPM3 expression was measured by
real-time qRT-PCR (top plots of A and B). X axis represents samples and Y axis relative TPM3 expression ratio (siTPM or siNEG/control). Error bars
represent mean ± standard error of mean. Human GAPDH gene was used as internal control. TPM3 expression was also measured by western
blot (bottom plots of A and B). TPM3 band intensities of siTPM-treated cells are much weaker than those of siNEG-treated ones and control,
while internal control bands are consistent. Alpha-tubulin was used as internal control for western blot analysis. siTPM3, siTPM3 transfected HCC
cell line; siNEG, negative oligonucleotide (siNEG) transfected HCC cell line; control, HCC cell line without transfection.
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(P < 0.0001). In SNU-475, relative TPM3 expression
ratios were 0.91(95% CI 0.77-1.05) and 0.07(95% CI
0.06-0.08) in siNEG- and siTPM3-transfected cells,
respectively (P < 0.0001). TPM3 protein expression in
both siTPM-treated cells is much weaker than those in
siNEG-treated ones, while alpha-tubulin bands are
consistent (Figure 2A and 2B).
Effects of TPM3 silencing on HCC cell migration and
invasion
In order to explore the potential role of TPM3 on the
invasiveness of HCC cells, we performed cell migration
and invasion assays using siTPM3-treated HepG2 and
SNU-475. Both migration and invasion capacities were
found to be profoundly repressed in siTPM3-treated
cells (Figure 3). In both cell lines, the numbers of
Figure 3 Repressed migration and invasion in TPM3 knockdown HCC cell lines. (A) Migration of siTPM and siNEG transfected HCC cell lines
was examined using the Matrigel uncoated transwell membrane. After crystal violet staining, the numbers of colonies in five microscopic fields
(X200) were counted. In HepG2, 332.0 in siNEG-treated cells (95% CI 323.0-341.0) versus 29.3 in siTPM3-treated cells (95% CI 25.5-33.1), P < 0.0001;
In SNU-475, 359.3(95% CI 350.6-368.1) versus 125.3(95% CI 114.1-136.5), P < 0.0001. (B) Invasion of siTPM and siNEG transfected HCC cell lines was
examined using the Matrigel coated transwell membrane. In HepG2, 212.7 in siNEG-treated cells (95% CI 206.4-218.9) versus 43.0 in siTPM3-
treated cells (95% CI 36.4-49.6), P < 0.0001; In SNU-475, 162.7(95% CI 156.4-168.9) versus 33.7(28.5-38.8), P < 0.0001. Error bars represent
mean ± standard error of mean. * represents P value < 0.05.
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siNEG control (P < 0.0001, Figure 3A). Repression of
invasiveness by siTPM3 treatment was also observed.
The numbers of the cells that passed through the Matri-
gel-coated membrane significantly decreased in siTPM3-
treated cells compared with siNEG control (P <0 . 0 0 0 1 ,
Figure 3B).
E-cadherin and Snail expression in TPM3 knockdown HCC
cells
To explore the potential mechanisms of reduced
migration and invasion in TPM3 knockdown HCC
cells, we examined the expression patterns of E-cad-
herin and Snail, a known factor to repress E-cadherin
expression by binding to E-boxes of the E-cadherin
promoter in cancers. Before knockdown, we measured
the endogenous levels of E-cadherin and Snail in the
10 HCC cell lines and THLE-3 as a reference (Figure
4). Of the eight cell lines showing relative TPM3 over-
expression with respect to THLE-3, five cell lines
(SNU-387, 423, 475, 739, and HepG2) showed upregu-
lated Snail and downregulated E-cadherin levels. Two
of the eight cell lines with TPM3 overexpression
(SNU-449 and 878) also showed the Snail up- and E-
cadherin downregulated pattern, but the endogenous
Snail levels were lower than that in THLE-3. In case of
SNU-761, although it showed TPM3 overexpression,
the expression pattern of Snail and E-cadherin was
opposite to those of other 7 cell lines. The 2 cell lines
without TPM3 overexpression (SNU-398 and 886) did
not show Snail upregulation. When we knocked down
TPM3 in HepG2 and SNU-475, the expression levels
of Snail and E-cadherin became reversed in both cell
lines; Snail expression was significantly decreased and
E-cadherin was significantly increased compared with
the siNEG transfection control on both mRNA and
protein levels (Figure 5A and 5B).
Vimentin and fibronectin expression in TPM3 knockdown
HCC cells
To further verify the changes of EMT-related pheno-
types in TPM3 knockdown cells, we examined the
expression of vimentin and fibronectin in cells with and
without siTPM3 transfection. In SNU-475, endogenous
vimentin and fibronectin were strongly expressed in the
cytoplasm of control cells, but both signals decreased in
siTPM3-treated cells (Figure 6). Especially, the decrease
of vimentin expression after TPM3 knockdown was
more noticeable than that of fibronectin. The profile in
HepG2 was similar to that in SNU-475, but less
Figure 4 Endogenous Snail and E-cadherin expression in 10 HCC cell lines and a normal liver cell line (THLE-3). Endogenous expression
levels of Snail and E-cadherin were measured by real-time qRT-PCR before siTPM transfection. Total RNA extraction and qRT-PCR procedure were
as described in Materials and Methods. Human GAPDH gene was used as internal control for qRT-PCR. X axis represents cell lines and Y axis
represents relative expression ratios of each gene (Cell lines/THLE-3). Error bars represent mean ± standard error of mean. Open bar represents
Snail expression and closed bar represents E-cadherin expression.
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nectin signals than those in SNU-475 (data not shown).
Inhibited tumor cell growth after TPM3 silencing
In addition to the effects on tumor cell migration and
invasion, we also assessed the effect of TPM3 knock-
down on HCC cell growth (Figure 7). First, we per-
formed the colony formation assay. The numbers of
colonies in siTPM3 treated cells were significantly
reduced compared with those in siNEG treated cells;
In HepG2, 685.7(95% CI 663.1-708.2) in siNEG-treated
cells versus 108.3(95% CI 104.5-112.1) in siTPM3-
treated cells, P < 0.0001; In SNU-475, 190.0(95% CI
176.2-203.8) versus 107.3(95% CI 92.8-121.9), P < 0.0001
(Figure 7A and 7B). We next examined the TPM3
knockdown effect on the anchorage independent growth
of HCC cells by the soft agar assay. The numbers and
sizes of anchorage-independent colonies were signi-
ficantly lower in siTPM3-treated cells than those
in siNEG-treated ones; In HepG2, 212.7 (95% CI
206.4-218.9) in siNEG-treated cells versus 43.0(95% CI
36.4-49.6) in siTPM3-treated cells, P < 0.0001; In
SNU-475, 162.7(95% CI 156.4-168.9) versus 33.7(95% CI
28.5-38.8), P < 0.0001 (Figure 7A and 7B).
Discussion
Previously, we reported a recurrent chromosomal ampli-
fication on the 1q21.3 region and related overexpression
of the TPM3 gene and suggested its oncogenic potential
in hepatocarcinognenesis [6]. Subsequently, we con-
ducted this study to elucidate the biological effects of
TPM3 overexpression in hepatocarcinogenesis using the
RNA interference (RNAi) technology to knockdown the
expression of TPM3. We found that TPM3 knockdown
Figure 5 Changes in E-cadherin and Snail expression after TPM3 knockdown in HepG2 (A) and SNU-475(B). After TPM3 knockdown, E-
cadherin and Snail expression levels were measured by real-time qRT-PCR (top plots). * represents P value < 0.05. X axis represents samples and
Y axis represents relative expression ratios of E-cadherin and Snail (siTPM/siNEG). Human GAPDH gene was used as internal control for qRT-PCRs.
E-cadherin and Snail expression levels were also measured by western blot (bottom plots). Alpha-tubulin was used as internal control for
western blot analysis. siTPM3, siTPM3 transfected HCC cell line; siNEG, negative oligonucleotide transfected HCC cell line. Error bars represent
mean ± standard error of mean. * represents P value < 0.05.
Choi et al. BMC Cancer 2010, 10:122
http://www.biomedcentral.com/1471-2407/10/122
Page 7 of 11profoundly repressed the migration and invasion poten-
tials of HCC cells compared with the same cell lines
without siTPM3 treatment. These findings are accordant
with the previous reports which suggested that expres-
sion of a tropomyosin isoform was higher in highly
metastatic mouse tumor cells than in the cells with
lower metastatic rate [14].
To explore the mechanisms behind reduced migra-
tion and invasion in TPM3 knockdown HCC cells, we
examined whether transfection of siTMP3 would affect
t h el e v e l so fE - c a d h e r i ne x p r e s s i o ni nH C Cc e l l s .
Downregulation of E-cadherin expression is one of the
well-known hallmarks of tumor metastasis in HCC and
an indicator of EMT onset [18-21]. In our study, E-
cadherin expression was found to be reversed from
low to high through siTPM3 treatment. In previous
HCC studies, repressed expression or mutation of E-
cadherin was correlated with a histological grade,
vascular invasion and intrahepatic metastasis through
losing cell adhesion and increasing cell mobility
[16,22,23]. We further examined the expression of
Snail in TPM3 knockdown HCC cells showing upregu-
lated E-cadherin, because the Snail transcription factor
has been known to repress E-cadherin expression by
binding to E-boxes in the E-cadherin promoter in can-
cers including HCC [17,24,25]. Snail is also known as
a key regulatory molecule inducing EMT [17,22,26].
We found that Snail expression was significantly more
repressed in siTPM3-treated HCC cell lines than in
the untreated cell lines. Although directions of the
effect were opposite, there have been studies which
reported that overexpression of Snail increases the
invasiveness of HCC [17,27,28]. Based on our observa-
tions and previous reports, it can be hypothesized that
overexpression of TPM3 in the cytoplasm may activate
Snail which will subsequently repress E-cadherin
Figure 6 Expression profiles of vimentin and fibronectin after TPM3 knockdown in SNU-475. Vimentin (upper boxes) and fibronectin
(lower boxes) expression patterns were compared between siTPM3- and siNEG-transfected SNU-475 by immunofluorescence staining (green for
vimentin and fibronectin stain; blue for nuclear DAPI stain). siTPM3, siTPM3 transfected SNU-475; siNEG, siNEG transfected SNU-475. ×400
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fer migration or invasion potentials to cancer cells dur-
ing hepatocarcinogenesis. Snail activation by TPM3
could be achieved through the direct interaction or
activation of TPM3 downstream signaling pathways.
However, we could not find the significant positive
correlation between endogenous TPM3 and Snail
mRNA levels, partly due to the limited number of cell
lines we studied.
To see phenotypic consequences of TPM3 knockdown
in HCC cells, we examined vimentin and fibronectin
expression. Vimentin and fibronectin are the mesenchy-
mal cell markers associated with EMT and known to be
upregulated in migratory cells [29]. In siTPM3 transfected
cells, the expression levels of vimentin and fibronectin
decreased compared with the untreated cells. All these
results support that TPM3 overexpression could affect
migration or invasion potentials through activating EMT.
Figure 7 Inhibited tumor cell growth in TPM3 knockdown HepG2 (A) and SNU-475 (B). Top plots of A and B are colony formation assay
results. Bottom plots are soft agar assay results. In both the colony formation and anchorage independent growth assays, the number of
colonies were counted in siTPM and siNEG plates. siTPM3, siTMP3 transfected HCC cell line; siNEG, negative oligonucleotide (siNEG) transfected
HCC cell line. * represents P value < 0.05.
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ony formation and anchorage independent growth. In
previous observations, upregulation of Snail was found
to be associated with tumor cell survival and aggressive
behavior of cancer [30,31]. Taken together, it could be
suggested that reduced tumor cell growth in siTPM3
treated HCC cells might be due to TPM3 knockdown-
related downregulation of Snail. In addition, in our
unpublished study, the combined use of TPM3 knock-
down and chemotherapeutic agents have been more
effective to reduce tumor cell viabilities than the use of
chemotherapeutic agents only. This is also coherent
with the previous reports suggesting that Snail expres-
sion is critical for cancer cells to acquire chemoresis-
tence [30,31].
There are several limitations in this study. First, we
did not examine the direct binding of TPM3 to Snail.
TPM3-Snail co-immunoprecipitation or other experi-
mental verification of the correlation of these two mole-
cules would be necessary. Second, although repression
of colony formation and anchorage independent growth
was observed in TPM3 knockdown cells, it cannot auto-
matically prove the biological consequences of TPM3
overexpression in hepatocarcinogenesis. Larger-scale
screening of TPM3 expression profile in invasive pri-
mary HCCs and TPM3 overexpression experiment in
normal liver cell lines will provide more direct evidence
to support its oncogenic potential. Lastly, it is unclear
whether the TPM3-Snail pathway is hepatocarcinogen-
esis-specific or not. Examining other types of cancers
will be required to clarify this possibility.
Conclusion
In this study, we demonstrated that TPM3 knockdown
profoundly repressed migration and invasion of HCC
cell lines. Based on our findings, we formulate a hypoth-
esis that overexpression of TPM3 activates Snail expres-
sion, which will repress E-cadherin expression and
confer migration or invasion potentials to HCC cells
during hepatocarcinogenesis. To our knowledge, this is
the first evidence that TPM3 gets involved in migration
and invasion of HCC by activating Snail mediated EMT
pathway. This study will help to understand invasion or
metastasis mechanisms in HCC and to define therapeu-
tic targets inhibiting them.
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